188 related articles for article (PubMed ID: 38536018)
1. Identification and validation of the biomarkers related to ferroptosis in calcium oxalate nephrolithiasis.
Hou C; Zhong B; Gu S; Wang Y; Ji L
Aging (Albany NY); 2024 Mar; 16(7):5987-6007. PubMed ID: 38536018
[TBL] [Abstract][Full Text] [Related]
2. Activation of liver X receptor suppresses osteopontin expression and ameliorates nephrolithiasis.
Chen J; Zhang D; Ji MF; Liu T; Mei CL; Tang XJ
J Cell Physiol; 2019 Aug; 234(8):14109-14122. PubMed ID: 30623435
[TBL] [Abstract][Full Text] [Related]
3. Untargeted and targeted metabolomics reveal bile acid profile changes in rats with ethylene glycol-induced calcium oxalate nephrolithiasis.
Zhou Z; Feng D; Shi D; Gao P; Wang L; Wu Z
Chem Biol Interact; 2023 Aug; 381():110570. PubMed ID: 37244400
[TBL] [Abstract][Full Text] [Related]
4. p53 deacetylation alleviates calcium oxalate deposition-induced renal fibrosis by inhibiting ferroptosis.
Ye Z; Xia Y; Li L; Li B; Chen L; Yu W; Ruan Y; Rao T; Zhou X; Cheng F
Biomed Pharmacother; 2023 Aug; 164():114925. PubMed ID: 37236026
[TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone Suppresses Calcium Oxalate Crystal Binding and Oxalate-Induced Oxidative Stress in Renal Epithelial Cells by Promoting PPAR-
Liu YD; Yu SL; Wang R; Liu JN; Jin YS; Li YF; An RH
Oxid Med Cell Longev; 2019; 2019():4826525. PubMed ID: 31781338
[TBL] [Abstract][Full Text] [Related]
6. Oxygen nano-bubble water reduces calcium oxalate deposits and tubular cell injury in ethylene glycol-treated rat kidney.
Hirose Y; Yasui T; Taguchi K; Fujii Y; Niimi K; Hamamoto S; Okada A; Kubota Y; Kawai N; Itoh Y; Tozawa K; Sasaki S; Kohri K
Urolithiasis; 2013 Aug; 41(4):279-94. PubMed ID: 23754513
[TBL] [Abstract][Full Text] [Related]
7. Glycine suppresses kidney calcium oxalate crystal depositions via regulating urinary excretions of oxalate and citrate.
Lan Y; Zhu W; Duan X; Deng T; Li S; Liu Y; Yang Z; Wen Y; Luo L; Zhao S; Wang J; Zhao Z; Wu W; Zeng G
J Cell Physiol; 2021 Oct; 236(10):6824-6835. PubMed ID: 33772775
[TBL] [Abstract][Full Text] [Related]
8. Development of a two-stage model system to investigate the mineralization mechanisms involved in idiopathic stone formation: stage 2 in vivo studies of stone growth on biomimetic Randall's plaque.
O'Kell AL; Lovett AC; Canales BK; Gower LB; Khan SR
Urolithiasis; 2019 Aug; 47(4):335-346. PubMed ID: 30218116
[TBL] [Abstract][Full Text] [Related]
9. Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline.
Khan SR; Glenton PA; Byer KJ
Kidney Int; 2006 Sep; 70(5):914-23. PubMed ID: 16850024
[TBL] [Abstract][Full Text] [Related]
10. Autophagy-endoplasmic reticulum stress inhibition mechanism of superoxide dismutase in the formation of calcium oxalate kidney stones.
Kang J; Sun Y; Deng Y; Liu Q; Li D; Liu Y; Guan X; Tao Z; Wang X
Biomed Pharmacother; 2020 Jan; 121():109649. PubMed ID: 31733571
[TBL] [Abstract][Full Text] [Related]
11. Metformin ameliorates calcium oxalate crystallization and stone formation by activating the Nrf2/HO-1 signaling pathway: Two birds with one stone.
Zhang X; Liang F; Li T; Jiang Y; Ren F
Arch Biochem Biophys; 2023 May; 739():109568. PubMed ID: 36914110
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis in calcium oxalate kidney stone formation and the possible regulatory mechanism of ANKRD1.
Zhao J; Wu Y; Zhou K; Huang M; Sun Y; Kang J; Su Q; Zhao Y; Liu Q; Li C
Biochim Biophys Acta Mol Cell Res; 2023 Jun; 1870(5):119452. PubMed ID: 36907445
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of Incarvillea diffusa Royle extract in the formation of calcium oxalate nephrolithiasis by regulating ROS-induced Nrf2/HO-1 pathway in rats.
Gao M; Meng T; Chen F; Peng M; Li Q; Li L; Yang L; Yan Y; Deng T; Pan X; Luo Z; Yang J; Yang X
J Ethnopharmacol; 2024 May; 325():117619. PubMed ID: 38272103
[TBL] [Abstract][Full Text] [Related]
14. Ferrostatin‑1 alleviates oxalate‑induced renal tubular epithelial cell injury, fibrosis and calcium oxalate stone formation by inhibiting ferroptosis.
Xie J; Ye Z; Li L; Xia Y; Yuan R; Ruan Y; Zhou X
Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35703358
[TBL] [Abstract][Full Text] [Related]
15. Mucin 4 Gene Silencing Reduces Oxidative Stress and Calcium Oxalate Crystal Formation in Renal Tubular Epithelial Cells Through the Extracellular Signal-Regulated Kinase Signaling Pathway in Nephrolithiasis Rat Model.
Sun L; Zou LX; Wang J; Chen T; Han YC; Zhu DD; Zhuo SC
Kidney Blood Press Res; 2018; 43(3):820-835. PubMed ID: 29843125
[TBL] [Abstract][Full Text] [Related]
16. Genome-Wide Gene Expression Profiling of Randall's Plaques in Calcium Oxalate Stone Formers.
Taguchi K; Hamamoto S; Okada A; Unno R; Kamisawa H; Naiki T; Ando R; Mizuno K; Kawai N; Tozawa K; Kohri K; Yasui T
J Am Soc Nephrol; 2017 Jan; 28(1):333-347. PubMed ID: 27297950
[TBL] [Abstract][Full Text] [Related]
17. Temporal changes in mRNA expression for bikunin in the kidneys of rats during calcium oxalate nephrolithiasis.
Iida S; Peck AB; Johnson-Tardieu J; Moriyama M; Glenton PA; Byer KJ; Khan SR
J Am Soc Nephrol; 1999 May; 10(5):986-96. PubMed ID: 10232684
[TBL] [Abstract][Full Text] [Related]
18. Premature Senescence and Telomere Shortening Induced by Oxidative Stress From Oxalate, Calcium Oxalate Monohydrate, and Urine From Patients With Calcium Oxalate Nephrolithiasis.
Chuenwisad K; More-Krong P; Tubsaeng P; Chotechuang N; Srisa-Art M; Storer RJ; Boonla C
Front Immunol; 2021; 12():696486. PubMed ID: 34745087
[TBL] [Abstract][Full Text] [Related]
19. Role of ferroptosis induced by a high concentration of calcium oxalate in the formation and development of urolithiasis.
He Z; Liao W; Song Q; Li B; Liu J; Xiong Y; Song C; Yang S
Int J Mol Med; 2021 Jan; 47(1):289-301. PubMed ID: 33416117
[TBL] [Abstract][Full Text] [Related]
20. CAV1 alleviated CaOx stones formation
Yang Y; Hong S; Lu Y; Wang Q; Wang S; Xun Y
PeerJ; 2022; 10():e14033. PubMed ID: 36128191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
